Insider Selling: Halozyme Therapeutics (NASDAQ:HALO) COO Sells 20,000 Shares of Stock

Halozyme Therapeutics (NASDAQ:HALO) COO Cortney Caudill sold a total of 28,857 shares of the company’s stock on March 9th and March 10th, amounting to approximately $1.955 million. These transactions reduced her stake in the company by 58.2%. The insider selling comes after Halozyme reported a significant earnings per share miss in its latest quarterly results, though revenue grew by 51.6%.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin